{"url_path":"/sec/cpmd/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1081938/0001654954-26-005180-index.html","accession_number":"0001654954-26-005180","cik":"0001081938","ticker":"CPMD","issuer_name":"CANNAPHARMARX, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1081938/0001654954-26-005180-index.html","primary_entity_key":"0001081938","primary_entity_name":"CANNAPHARMARX, INC."},"word_count":44,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n \n\nDuring the three months ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.\n\n \n\n \n\n30\n\n*Table of Contents*"}